Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Physical and mental characteristics post-COVID-19 infection

Researchers conducted symptom assessment, cognitive tests, and physical measurements after COVID-19 infections.

21 Apr 2022

Researchers develop and validate polygenic risk scores for six common diseases

A person's risk of developing diseases such as type 2 diabetes or breast cancer may be influenced by thousands of genetic differences.

18 Apr 2022

Researchers calculate the impact of consuming ultra-processed foods on obesity risk

Based on data for 3,587 adolescents aged 12-19 who took part in the 2011-16 National Health and Nutrition Examination Survey (NHANES) in the United States, researchers at the University of São Paulo (USP) in Brazil have calculated the impact of consuming ultra-processed foods on the risk of obesity.

12 Apr 2022

Consensus document offers recommendations on genetic testing for inherited cardiac diseases

When should patients and family members undergo genetic assessment for a heart condition? Find out in an international consensus document published in EP Europace, a journal of the European Society of Cardiology and presented at EHRA 2022, a scientific congress of the ESC.

4 Apr 2022

The longest duration of SARS-CoV-2 positivity after initial diagnosis

An immunocompetent individual with prolonged SARS-CoV-2 shedding 221 days after their initial COVID-19 diagnosis.

31 Mar 2022

3-T unenhanced Dixon GRE performs higher than current standard for unenhanced coronary MRA

According to ARRS' American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) sequence performed higher than the current standard of 1.5-T SSFP for unenhanced coronary MRA, which could help expand clinical adoption of the procedure.

28 Mar 2022

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Antithrombotic therapy is prescribed to prevent thrombotic (blood clotting inside a blood vessel) events but the treatment also increases the likelihood of experiencing a bleeding event, which can be extremely serious if it occurs in a vital organ.

25 Mar 2022

Computer algorithm predicts coronary artery disease-related events based on voice recordings

An artificial intelligence (AI)-based computer algorithm accurately predicted a person's likelihood of suffering heart problems related to clogged arteries based on voice recordings alone, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

24 Mar 2022

Daily coffee intake associated with benefits to heart health

Drinking coffee - particularly two to three cups a day - is not only associated with a lower risk of heart disease and dangerous heart rhythms but also with living longer, according to studies being presented at the American College of Cardiology's 71st Annual Scientific Session.

24 Mar 2022

Heart attack survivors with depression more likely to suffer a stroke

Depression can complicate and slow recovery from a heart attack, not to mention the toll it can take on one's mental outlook, relationships and joy of life.

23 Mar 2022

New smartphone app can calculate users’ genetic risk for coronary artery disease

A Scripps Research team developed a smartphone app that can calculate users' genetic risk for coronary artery disease (CAD) - and found that users at high risk sought out appropriate medication after using the app.

14 Mar 2022

New study analyzes COVID-19 outcomes in patients with cancer

If a cancer patient tests positive for COVID-19, are they more likely to become hospitalized from the disease?

10 Mar 2022

Using IgG antibody assay to Identify natural SARS-CoV-2 infection in vaccinees

A recent study published in the journal of Mayo Clinic Proceedings predicted the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural infection in vaccinated individuals.

21 Feb 2022

First study in North America uses genetic testing to identify people at risk of heart disease

Dignity Health in Arizona is launching the first research study in North America in which genetic testing is used to identify men and women at risk of developing heart disease based on the makeup of their DNA.

21 Feb 2022

Study uncovers most critical genes that cause coronary heart disease

The most critical genes that cause coronary heart disease and trigger heart attacks have been identified in a major new study.

15 Feb 2022

Cardiovascular markers for predicting clinical outcomes in SARS-CoV-2 infection

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from Toronto, Canada, characterized the markers of endothelial function and developed micro ribonucleic acid (miRNA) expression atlas in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive and -negative patients admitted to the intensive care unit (ICU).

15 Feb 2022

Enhanced external counterpulsation therapy benefits long COVID-19 patients

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest discomfort, after undergoing 15-35 hours of enhanced external counterpulsation (EECP) therapy.

14 Feb 2022

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

In a new study, scientists have evaluated patient-reported and clinically tested neuropsychological problems in both ambulatory (outpatients) and hospitalized COVID-19 patients during the early recovery phase.

8 Feb 2022

COVID-19 patients are at high risk of developing heart problems up to a year after infection

An analysis of federal health data indicates that people who have had COVID-19 are at increased risk of developing cardiovascular complications within the first month to a year after infection, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

7 Feb 2022

Drugs derived from activated protein C may limit ischemia and reperfusion injury, study suggests

A University of South Florida Health preclinical study offers molecular insight into how activated protein C (APC) may improve aging patients' tolerance to reperfusion injury – a potentially adverse effect of treatment for ischemic heart disease.

31 Jan 2022

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Physical and mental characteristics post-COVID-19 infection

Researchers develop and validate polygenic risk scores for six common diseases

Researchers calculate the impact of consuming ultra-processed foods on obesity risk

Consensus document offers recommendations on genetic testing for inherited cardiac diseases

The longest duration of SARS-CoV-2 positivity after initial diagnosis

3-T unenhanced Dixon GRE performs higher than current standard for unenhanced coronary MRA

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Computer algorithm predicts coronary artery disease-related events based on voice recordings

Daily coffee intake associated with benefits to heart health

Heart attack survivors with depression more likely to suffer a stroke

New smartphone app can calculate users’ genetic risk for coronary artery disease

New study analyzes COVID-19 outcomes in patients with cancer

Using IgG antibody assay to Identify natural SARS-CoV-2 infection in vaccinees

First study in North America uses genetic testing to identify people at risk of heart disease

Study uncovers most critical genes that cause coronary heart disease

Cardiovascular markers for predicting clinical outcomes in SARS-CoV-2 infection

Enhanced external counterpulsation therapy benefits long COVID-19 patients

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

COVID-19 patients are at high risk of developing heart problems up to a year after infection

Drugs derived from activated protein C may limit ischemia and reperfusion injury, study suggests

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in